Applied Molecular Biology/Biochemistry Institute and Center of Investigation in Environment, Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Cancer Invest. 2012 Jun;30(5):331-42. doi: 10.3109/07357907.2012.659925. Epub 2012 Feb 21.
The involvement of apoptosis in the cytotoxicity mediated by nucleoside analogues, namely azaguanine, and its implication in resistance are not well understood. Using human T-cell acute lymphoblastic leukemia cell lines, sensitive (CEM cells) and resistant to azaguanine (CM3 cells), we observe a decrease in the expression of proapoptotic proteins in CM3 cells, which may be related to the resistance to cell death induced by azaguanine. On the other hand, CM3 cells lack cross resistance with other anticarcinogenic drugs, suggesting that azaguanine may be used alternatively in the presence of chemoresistance. A better knowledge of the apoptotic pathways involved in leukemic cell death resistance may contribute to the development of therapeutic strategies, aimed to prevent chemotherapy resistance.
细胞凋亡在核苷类似物(如阿扎胞苷)介导的细胞毒性及其在耐药性中的作用尚不清楚。本研究使用人 T 细胞急性淋巴细胞白血病细胞系,包括对阿扎胞苷敏感(CEM 细胞)和耐药(CM3 细胞)的细胞系,观察到 CM3 细胞中促凋亡蛋白表达降低,这可能与阿扎胞苷诱导的细胞死亡耐药性有关。另一方面,CM3 细胞与其他抗癌药物无交叉耐药性,表明在存在化疗耐药性的情况下,阿扎胞苷可能被替代使用。更好地了解白血病细胞死亡耐药性中涉及的凋亡途径可能有助于制定治疗策略,以防止化疗耐药性。